Senior insider sale
CEO - Elect at TAKEDA PHARMACEUTICAL CO LTD — senior position signals high conviction
$490.5K
37.22K shares
What this filing means
KIM JULIE SO-YOUNG plans to sell 37.22K shares of TAKEDA PHARMACEUTICAL CO LTD valued at approximately $490.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/10/2024ACC: 0001395064-24-000144
Officer· CEO - Elect
Since Mar 2026
37.22K
Shares to sell
$490.5K
Approx. market value
78.47K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit Awards - Vested.
Compensation
7/1/2024
78.47KTotal acquired78.47K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/1/2024 | Restricted Stock Unit Awards - Vested. Compensation | 78.47K | — |
| Total | 78.47K | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
37.22K
Market value
$490.5K
7/11/2024
Total
Units
37.22K
Value
$490.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/11/2024 | 37.22K | $490.5K | NYSE | Planned |
| Total | 37.22K | $490.5K | ||